Featured
Read our handpicked blogs, curated for you.
|
Enterprise technology departments hit a critical performance bottleneck when trying to scale learning applications to…
|
The traditional corporate training paradigm forces a deep operational paradox upon the modern enterprise. While…
|
You invested millions in an automated claims platform. It processes documents faster in testing. Yet in production it…
Recent releases
|
What Every CMO Wants From Their Pharma Tech Stack in 2025
Five years ago, tech stack conversations in pharma happened in IT departments. Today, they sit squarely on the CMO’s desk. Marketing leaders no longer care about tools in isolation, they care about…
|
Tier 2 and Tier 3 Doctors The Untapped Goldmine of Indian Pharma Marketing
For decades, Indian pharma marketing has revolved around Tier 1 cities. Mumbai, Delhi, Bangalore, Chennai- this is where companies concentrated their field force, budgets, and campaigns. But here’s…
|
Tier 2 and Tier 3 Doctors: Pharma’s Untapped Growth Engine
For years, Indian pharma marketing has been obsessed with metros. Strategies are designed for doctors in Mumbai, Delhi, Bangalore, and Hyderabad, as if prescribing behavior outside these hubs hardly…
|
Cutting Pharma Content Approval Cycles with Modular Ops
Every pharma marketer in India knows the feeling. A new campaign is planned, deadlines are set, and the brand team is ready to move. Then the medical-legal-regulatory (MLR) process begins. Weeks go…
